Novo Nordisk's reports of side effects leap after inspection

Just a few months after an FDA inspection found Novo Nordisk was delaying some reports about side effects and failing to submit others, the company submitted almost 11,000 reports about its drugs containing semaglutide within one week in July 2025.


Altogether, Novo Nordisk has submitted over 50,000 semaglutide reports since 2020, including at least 600 deaths.

info Tap buttons below to filter Novo Nordisk's reports by type of reaction and tap bars below for details.
info Click buttons below to filter Novo Nordisk's reports by type of reaction. Hover over bars for more details.

Deaths

Serious Reactions

Non-Serious Reactions

Reactions to semaglutide

(Ozempic, Wegovy, Rybelsus) 05001,0001,5002,0002,500202120222023202420252026FDA finds underreportingat Novo Nordisk inspection

SOURCE: FDA Adverse Event Monitoring System Public Dashboard, downloaded March 16, 2026.

NOTE: The FDA cautions that these reported reactions could be related to the underlying disease being treated, caused by some other drug taken concurrently or occurred for other reasons.